Neurology News

As a wife, mother, community specialist and owner of an independent practice, I often am torn in millions of directions — and the pressure can be tremendous.

A psychological sleep intervention reduced severity of insomnia and mental health symptoms as early as 3 months in young people at ultra-high risk for psychosis and warrants further study, according to research in The Lancet Psychiatry.

Older women with Parkinson’s disease were less physically active and spent more time being sedentary compared with those without Parkinson’s disease, which may increase their risk for adverse outcomes, according to researchers.

An Italian pharmaceutical company and a Boston-area biotechnology research firm announced a partnership to advance a novel blood-brain barrier-crossing platform technology for those with lysosomal storage disorders.

After you have decided to pursue a sale transaction, inevitably one of the biggest topics you’ll come across during the negotiation phase with the buyer is the non-compete restriction.

Longer-term treatment with ofatumumab led to lessening of disability progression and slowing of brain volume loss, according to Jeffrey A. Cohen, MD, in this Healio video.

Research supports an association between sleep and brain health, and suggests that people who have consistent difficulty initiating and staying asleep may be negatively impacted.

Peer victimization and suicidality were associated with higher headache frequency in adolescents, while the association between headache and gender diversity weakened after controlling for other factors, according to research in Neurology.

The FDA has granted orphan drug designation to Avidity Biosciences Inc. for AOC 1044, its investigational monoclonal antibody to treat Duchenne muscular dystrophy in those with mutations amenable to exon 44 skipping.

A Bay Area clinical research and development firm announced it will discontinue development of a novel therapeutic for Alzheimer’s disease.